key: cord-0804036-ban8094g authors: Ragamin, Aviël; de Wijs, Linde E. M.; Hijnen, Dirk‐Jan; Arends, Nicolette J. T.; Schuttelaar, Marie L. A.; Pasmans, Suzanne G. M. A.; Bronner, Madelon B. title: Care for children with atopic dermatitis in the Netherlands during the COVID‐19 pandemic: Lessons from the first wave and implications for the future date: 2021-08-29 journal: J Dermatol DOI: 10.1111/1346-8138.16130 sha: 8aff0ee5a6681a8a7e53eb23774a7f9390030e70 doc_id: 804036 cord_uid: ban8094g The first wave of the coronavirus disease 2019 (COVID‐19) pandemic had an enormous impact on health‐care services, including on care provision for children with atopic dermatitis (AD). We investigated the impact of COVID‐19 on the care for children with moderate to severe AD at our tertiary outpatient clinic and examined satisfaction with care. We reviewed outpatient records, comparing total number and types of consultations during the first COVID‐19 wave (March until July 2020) with the corresponding months of 2019 and 2018. In addition, we conducted a questionnaire‐based study investigating the impact of COVID‐19 on clinical and psychological symptoms, and satisfaction with care. A total number of 913 consultations (466 individual children) were conducted during the first COVID‐19 wave in 2020, while 698 (391 individual children) and 591 consultations (356 individual children) were conducted in 2019 and 2018. The proportion of remote consultations was higher (56.2%) compared to 14.0% in 2019 and 12.7% in 2018. Worsening of AD was reported by 9.7% of caretakers. Overall satisfaction with provided care was high (8.6; interquartile range [IQR] = 7.3–10.0). Caretakers receiving face‐to‐face consultation were significantly (p = 0.026) more satisfied (9.0; IQR = 8.0–10.0) than caretakers receiving remote consultation (7.9; IQR = 7.0–9.5). The COVID‐19 pandemic had an unprecedented impact on care provision for children with AD, particularly on the number of remote consultations. Overall satisfaction with care was high. The impact of COVID‐19 on disease severity remained limited. Remote consultations seem to be a useful tool that can be put into practice during the COVID‐19 pandemic. informing and training children and caretakers in AD treatment is essential, since adequate treatment management skills are necessary for a successful treatment. 7 Continuity of care for these children is therefore important. Since the first case of COVID-19 in the Netherlands, 8 the coronavirus has affected many people and challenged the Dutch healthcare system. Although COVID-19 itself may cause fewer symptoms and has a better prognosis in children compared to adults, 9 the care for children with AD was affected by the restrictions to prevent spread of the novel coronavirus. 10 From March to July 2020, hospitals were forced to downscale non-COVID care. 11 A survey among dermatologists showed rapid adaptation of remote care during the COVID-19 pandemic. [12] [13] [14] At our outpatient clinic KinderHaven, a specialized, academic outpatient clinic for children with difficult to treat and moderate to severe atopic diseases, we expanded remote care and reduced the number of face-to-face consultations, while aiming to continue providing care. In the current second wave of the COVID-19 pandemic, 15 evaluation of care and sharing experiences is important to optimize care provision during this second wave or a pandemic in general. Therefore, the aim of our study was to evaluate the effect of the first COVID-19 wave on the care for children with moderate to severe AD and their caretakers at our AD expert center and to investigate the use and satisfaction with remote care. In addition, the effect of COVID-19 on clinical and psychological symptoms was investigated. This study was conducted at KinderHaven, an outpatient expert clinic for children with atopic diseases of Erasmus MC University Medical Centre-Sophia Children's Hospital-Kinderhaven, Rotterdam, the Netherlands. In Kinderhaven, children with AD and other atopic diseases (food allergy, asthma and allergic rhinitis) are diagnosed and treated (multidisciplinary). This specialized, academic outpatient clinic focuses primarily on treating children with difficult to treat (caused by comorbidities or social factors) and moderate to severe atopic diseases. During the COVID-19 pandemic, patients were screened approximately 2 weeks before planned consultations in order to determine which consultation would be suitable to change from face-to-face consultation into a remote consultation (telephone consultation with or without patient captured clinical images with emails) and which could be postponed. In most cases, screening was conducted by the treating physician. During this process, disease severity, patient needs and preferences influenced the type of care provided. In the first 3 weeks of the pandemic, remote consultations were used for newly referred patients. Face-to-face consultations were conducted at a later stage for these patients. In addition to planned consultations, caretakers of children receiving care at our outpatient clinic could request consultations by telephone or email. All caretakers were then informed on the COVID-19 regulations at our clinic by telephone, mail or email. Caretakers of children with systemic immunomodulatory drugs received a letter with information on the use of systemic treatment (e.g., dupilumab, cyclosporin) during the COVID-19 pandemic. First, a retrospective study was performed to evaluate the type (newly referred face-to-face consultation, follow-up face-to-face consultation, follow-up remote consultation, telephone consultation with or without patient captured clinical images) and number of consultations conducted during the first COVID-19 wave (1 March until 1 July 2020). Thereafter, we compared consultations during this period with consultations in the corresponding period of 2018 and 2019. Data were retrieved by searching our electronic patient records for consultations at our specialized AD clinic. Second, an online questionnaire was sent to all caretakers of children with AD with an available email address and who consulted our outpatient clinic during the first COVID-19 wave (1 March to 1 July 2020). The questionnaire was sent by email to caretakers in July 2020 and a reminder was sent after 4 weeks. The ques- [16] [17] [18] The PSQ measures caretakers' satisfaction based on five items: (i) addressing needs; (ii) active involvement in interaction; (iii) information received; (iv) emotional support received; and (v) interaction in general. Answers were given on Visual Analog Scales (VAS) ranging 0-100 with higher scores indicating higher satisfaction. Descriptive statistics were used to describe differences in consulta- This study, as well as our study investigating COVID-19 in our adult outpatient clinic, 19 was approved by the local Medical Research Ethics (MEC-2020-0413). All participants gave consent to use the collected data for scientific research. A questionnaire was sent to all available email addresses (368/466) of caretakers who received care for their child during the first COVID-19 wave. The questionnaire was completed by 144 caretakers (response rate = 39.1%). An overview of patient characteristics is presented in Table 1 . The majority of children were male (62.5%) with a median age of 6.0 years (interquartile range [IQR] = 2.0-11.0), 28.5% under the age of 2 years, and 21.5% were 12 years or older. No significant differences in age (p = 0.58), sex (p = 0.09), and type of consultation A small proportion of children ( General satisfaction with care was high. Only 1.9% caretakers were (very) unsatisfied with the care their child received during the first COVID-19 wave ( "physical examination is important", "face-to-face consultations raise treatment adherence", and "face-to-face consultations are more efficient". This study shows that the first wave of the COVID-19 pandemic Other 55.6% (5) Tested for COVID-19, (n) 4.9% (7) Tested negative 4.9% (7) Stress related to COVID-19 In Satisfaction with remote consultation was high, although caretakers considering their children to be more vulnerable were less satisfied with remote consultation. In the first part of this study, we showed an increase in individual patients that consulted our outpatient clinic, even when corrected for an average annual growth of 7.4% at our center. 20 During this pandemic, usage of remote care has increased rapidly 21 used. Overall, these results suggest that the impact of COVID-19 on children with AD remains limited when care provision is continued using remote care. This is supported by another study which found no differences in outcome between patients with AD treated remotely and face to face. 28 Therefore, dermatologists should consider to continue care by remote consultations during this COVID-19 pandemic, as recommended by the American Academy of Dermatology 29 and British Association of Dermatologists. 30 Concerning the use of remote consultations in general, remote care has potential to be a useful tool in addition to face-to-face consultations. Similar to studies investigating telemedicine, general satisfaction with remote consultations was high. 31 However, we noted that caretakers experienced less emotional support during remote consultation. Therefore, extra attention should be given to emotional support when conducting remote care, especially when clinical images are provided. In our study, almost a third would like to have more remote consultations in the future, particularly for regular follow-up visits and when the disease is controlled. This preference is in accordance with earlier findings that show that a third of patients preferred remote consultation over traditional face-to-face consultation 32 and patients are interested in using remote consultation in the future. 33 Additionally, a relative small study demonstrated the effectiveness of remote consultation in patients with AD. 28 This finding is supported by systematic reviews and meta-analyses which demonstrate the effectiveness of remote care in general. 26 However, further research is needed to investigate implementation, challenges, 34 This study has some shortcomings that should be mentioned. A limitation of this study was the relatively small sample size and response rate. However, our non-responder analysis demonstrated no differences in age, sex, and consultation type. Furthermore, results of our study may overestimate satisfaction with received care. During the first COVID-19 wave, appreciation of health care was high 37 and caretakers understood difficulties of providing care, possibly leading to response bias. It would be interesting to repeat this study after the COVID-19 pandemic and compare differences in satisfaction. Finally, since patients were screened based on disease severity and individual preferences (i.e., patients with severe disease activity may have been more likely to receive face-to-face consultation or remote consultation with clinical images), direct comparison of these groups should be done with careful consideration. In conclusion, the first wave of the COVID-19 pandemic had an unprecedented impact on the care for children with AD, particularly on the number of provided remote consultations. Effects on disease severity remained limited and overall satisfaction with care was high. However, caretakers considering their child to be vulnerable to COVID-19 were less satisfied with remote consultations. Extra attention should be given to emotional support during remote care with these families. Remote consultations seem to be a useful tool that can be put into practice during the COVID-19 pandemic and in general. The authors thank Max C. van der Klooster, BSc, for his support in the analysis of the consultations and the Data and Analytics Department of the Erasmus MC, University Medical Center, Rotterdam, the Netherlands for their support in the data collection. None declared. Aviël Ragamin https://orcid.org/0000-0003-3120-6653 Atopic dermatitis Atopic dermatitis in children: clinical features, pathophysiology, and treatment Basic skin care and topical therapies for atopic dermatitis: essential approaches and beyond Managing childhood eczema: qualitative study exploring carers' experiences of barriers and facilitators to treatment adherence The impact of pediatric atopic dermatitis on families: a review Quality of life of parents of children with atopic dermatitis Parental treatment management skills in paediatric atopic dermatitis Patient with novel coronavirus COVID-19 in the Netherlands: Ministry of Health, Welfare and Sport Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults Nieuwe maatregelen tegen verspreiding coronavirus in Nederland: Rijksoverheid Nu meer dan 900 patiënten op ic: 'operatie corona' is race tegen de klok. Algemeen Dagblad Impact of covid-19 pandemic on dermatology practice: results of a web-based, global survey Teledermatology in the era of COVID-19: experience of an academic department of dermatology Analysis of availability, types, and implementation of teledermatology services during COVID-19 COVID-19: are we ready for the second wave A comparison of counselee and counselor satisfaction in reproductive genetic counseling Satisfaction with the outpatient encounter: a comparison of patients' and physicians' views The impact of oncologists' behaviors on patient satisfaction with morning rounds COVID-19 in patients with cutaneous immune-mediated diseases in The Netherlands: real-world observational data Aantal DBC's per afgeleid zorgproduct aan aanvangsjaar Use of telemedicine and virtual care for remote treatment in response to COVID-19 pandemic What worries parents when their preschool children are acutely ill, and why: a qualitative study The impact of a dedicated contact centre on the clinical outcome of patients with inflammatory bowel disease during the COVID-19 outbreak Patient satisfaction with telemedicine during the COVID-19 pandemic: retrospective cohort study Teledermatology for acne during COVID-19: high patients' satisfaction in spite of the emergency Effectiveness and costeffectiveness of ehealth interventions in somatic diseases: a systematic review of systematic reviews and meta-analyses Parents' stress and children's psychological problems in families facing the COVID-19 outbreak in Italy Patient-centered, direct-access online care for management of atopic dermatitis: a randomized clinical trial Dermatologists can use telemedicine during COVID-19 outbreak: American Academy of Dermatology British Society for Paediatric Dermatology guidance on how to recommence paediatric dermatology services British Association of Dermatologist Telehealth and patient satisfaction: a systematic review and narrative analysis Patients' satisfaction with and preference for telehealth visits Patient and physician perspectives on teledermatology at an academic dermatology department amid the COVID-19 pandemic Optimizing teledermatology: looking beyond the COVID-19 pandemic Fighting COVID-19: early teledermatology lessons learned Definitions, survey methods, and findings of patient satisfaction studies in teledermatology: a systematic review 00 uur klapten Nederlanders voor 'onze helden': NOS